Skip to content

Frontoparietal Priority Maps as Biomarkers for MTBI

Frontoparietal Priority Maps as Biomarkers for MTBI

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02251002
Enrollment
88
Registered
2014-09-26
Start date
2015-07-31
Completion date
2018-10-31
Last updated
2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Motility Disorders, TBI (Traumatic Brain Injury)

Brief summary

The purpose of this study is to determine whether there is a quantitative relationship between brain processes seen by a MRI and visual deficits caused by mild to moderate traumatic brain injuries (mTBI).

Detailed description

Participants with mTBI, as well as healthy control participants, will be invited to participate in up to two study visits. Both visits will occur at the University of Minnesota's Center for Magnetic Resonance Research (CMRR). The first study visit will entail (1) interviews to determine the presence of (and, if present, the severity of) oculomotor difficulties such as convergence insufficiency, and (2) behavioral measures (e.g., visually track a moving dot) to assess skill at allocating spatial attention. For participants who have not before participated in an MRI study at the CMRR, a 15-minute scan to acquire research-quality anatomical images of the brain will be acquired at the end of the first visit. A subset of the approximately 88 participants who participate in Visit 1 will be invited to participate in Visit 2. Visit 2 will be dominated by a 90-minute scanning session in the 7 Tesla scanner, during which participants will perform a 10-minute spatial attention task and a 10-minute eye movement task, and high-resolution diffusion tensor imaging data will be acquired while participants enjoy the movie of their choice in the scanner.

Interventions

None listed

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Normal or corrected to normal visual acuity * No previously documented mTBI (target: 16 out of 88 participants invited for Visit 1) * Previously documented mTBI (target: 72 out of 88 participants invited for Visit 1) * Vision impairment (target: 48 out of 88 participants invited for Visit 1; expected to be comorbid with mTBI, but non-TBI participants with oculomotor impairments will not be excluded)

Exclusion criteria

* Current use of neuroactive drugs or medications * Presence of neurological disorders (other than mTBI and mild PTSD) * Contraindications for MRI (metal in the body, claustrophobia, diabetes or other diseases or drugs that affect thermoregulation) * Inability to comply with behavioral task instructions

Design outcomes

Primary

MeasureTime frameDescription
oculomotor performancestudy enrollment / baselineOculomotor performance will be measured with behavioral questionnaires, eye-charts, and computerized eye-tracking while subjects perform saccades and smooth pursuit motions.

Secondary

MeasureTime frameDescription
frontoparietal priority mapsbaselineFunctional MRI data will be collected at 7 Tesla while subjects perform spatial attention and eye movement tasks.
white matter integritybaselineDiffusion tensor imaging data will be acquired at 7 Tesla and analyzed in a priori regions of interest adjacent to frontal and parietal functional regions of interest.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026